Skip to main content
OpenTrials

Clinical trial condition

Meningococcal Infections

Explore clinical trials studying Meningococcal Infections. Study availability and eligibility vary by location and protocol.

216 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Meningococcal Infections trial results

Completed

Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49

NCT04142242

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Investigational Site Number 8400026 Chandler, Arizona, United States
  • Investigational Site Number 8400003 San Diego, California, United States
  • Investigational Site Number 8400028 Waterbury, Connecticut, United States
  • Investigational Site Number 8400038 Clearwater, Florida, United States
View all 34 locations
View Trial Details
Completed

A Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Adolescents and Adults

NCT04886154

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Colorado Springs, Colorado, United States
  • GSK Investigational Site Longmont, Colorado, United States
  • GSK Investigational Site Doral, Florida, United States
  • GSK Investigational Site Miami Lakes, Florida, United States
View all 53 locations
View Trial Details
Completed

Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) in Older Adults in Turkey and Lebanon

NCT03869866

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Investigational Site Number : 4220001 Beirut, Lebanon
  • Investigational Site Number : 7920002 Ankara, Turkey (Türkiye)
  • Investigational Site Number : 7920001 Ankara, Turkey (Türkiye)
View Trial Details
Completed

Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age

NCT04318548

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Bell Gardens, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Oakland, California, United States
View all 53 locations
View Trial Details
Completed

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe

NCT03547271

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations
  • Investigational Site Number : 2031006 Chlumec nad Cidlinou, Czechia
  • Investigational Site Number : 2031013 Domažlice, Czechia
  • Investigational Site Number : 2031010 Jindřichův Hradec, Czechia
  • Investigational Site Number : 2031012 Jindřichův Hradec, Czechia
View all 33 locations
View Trial Details
Completed

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

NCT03537508

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Birmingham Pediatric Associates Site Number : 8400026 Birmingham, Alabama, United States
  • Southeastern Pediatric Associates Site Number : 8400003 Dothan, Alabama, United States
  • MedPharmics, LLC - Phoenix Site Number : 8400083 Phoenix, Arizona, United States
  • Northwest Arkansas Pediatric Clinic Site Number : 8400011 Fayetteville, Arkansas, United States
View all 70 locations
View Trial Details
Completed

Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine

NCT04707391

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Banning, California, United States
  • GSK Investigational Site Chula Vista, California, United States
  • GSK Investigational Site West Covina, California, United States
View all 69 locations
View Trial Details
Completed

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

NCT03691610

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Alabama Clinical Therapeutics Site Number : 8400036 Birmingham, Alabama, United States
  • Southeastern Pediatric Associates Site Number : 8400009 Dothan, Alabama, United States
  • MedPharmics, LLC - Phoenix Site Number : 8400013 Phoenix, Arizona, United States
  • Emmaus Research Center, Inc Site Number : 8400019 Anaheim, California, United States
View all 47 locations
View Trial Details
Completed

Effectiveness of GlaxoSmithKline Biologicals S.A's Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young Adults

NCT04502693

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Glendale, Arizona, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Bell Gardens, California, United States
View all 112 locations
View Trial Details

Related conditions